ClinChoice昆翎

About:

ClinChoice is a Reaserch and Deveiopment platform, It develops a innovative drugs and devices.

Website: https://www.clinchoice.com.cn

Top Investors: Goldman Sachs, Legend Capital, DFJ Growth, Lilly Asia Ventures, Oriza Seed Capital (Oriza Yuandian)

Description:

ClinChoice Kunling was established in Tianjin inSince its establishment, through its own organic growth and strategic mergers and acquisitions, ClinChoice has more than 3,000 clinical R&D professionals around the world, located in hot cities and regions of domestic and foreign pharmaceutical R&D, and has developed into a local clinical CRO enterprise model supporting innovative drug device R&D. . The company adheres to the connotation of "Kunxing Zhiyuan · Ling creates the future", which means to become an ideal partner for the clinical research and development of innovative pharmaceutical devices.

Total Funding Amount:

$212M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

1995-01-01

Contact Email:

info(AT)klserv.com

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2022-07-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai